PHPatrick D. Hsu

Patrick D. Hsu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Recognitions

Top Cited Scholar (2023)

Patrick D. Hsu has a total of 539 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Systematic mapping of the prokaryotic noncoding sequence space with a genomic language model

    by Gwanggyu Sun, Tim Hudelmaier, Joshua C. Gilligan, Gabriel A. Gonzalez, Peter Yin, Fangping Wan, Zijian (Carl) Ma, Matthew G. Durrant, Chiara Ricci-Tam, April Pawluk, et al.

    Prokaryotic genomes encode a vast repertoire of noncoding elements such as ribozymes, riboswitches, and CRISPR RNAs. The sequence-level diversity of these intergenic elements precludes alignment-based clustering that would enable annotation and discovery of novel noncoding RNA families. Here, we show that a genomic language model fine-tuned on prokaryotic intergenic sequences learns representations of noncoding elements from DNA sequence. We used these embeddings to organize 376 million intergenic regions from 1.3 terabase pairs of prokaryotic genomes and metagenomes into 5.14 million clusters. This approach nominated 20,149 clusters of putative structured RNAs with a candidate protein partner. Periodicity in token entropies revealed internal architecture, recovering CRISPR, TIGR and VIPR arrays together with their cognate effector proteins from sequence alone. Targeted clustering of bridge recombinase-adjacent sequences identified bridge RNA variants with longer guide recognition sequences than any characterized ortholog. Finally, we directed teams of AI agents to mine the database under researcher-defined criteria, uncovering divergent riboswitches, ribozymes, and other structured RNAs with biological hypotheses for their function. We release a publicly available database that transforms the dark matter of prokaryotic genomes into an explorable resource for human-agent molecular discovery.

  • Open Access

    Structural mechanism governing the directionality of bridge recombination

    by Masahiro Hiraizumi, Januka S. Athukoralage, Nicholas T. Perry, Eisuke Tsujimoto, Nami Shiojiri, Naoto Nagahata, Lauren Lee, Gwanggyu Sun, Matthew G. Durrant, Sita S. Chandrasekaran, et al.

    Bridge recombinases from the IS110 family of transposons, such as IS621, associate with a bridge RNA (bRNA) to mediate programmable recombination between donor DNA and target DNA 1,2 . Although insertion is mediated by the recombinase–bRNA complex, it remains unknown how IS621 elements are excised from host genomes to form the circular DNA intermediates required for transposition. Here we show that bRNA is weakly expressed from IS621 loci in the Escherichia coli genome and that the IS621 recombinase–bRNA complex mediates excision less efficiently than insertion. Furthermore, we present the cryo-electron microscopy structures of the IS621 recombinase–bRNA complex bound to excision DNA substrates, providing mechanistic insights into the excision reaction. Similar to the previously reported donor- and target-bound insertion complex 2 , the excision complex comprises two recombinase dimers, each accommodating the target- and donor-binding loops of the bRNA. However, DNA recognition differs notably between the two complexes. Although the donor and target DNAs form a bent U-shape during insertion 2 , the excision substrates adopt linear conformations and bind across both bRNA loops, forming an X-shaped structure. This geometry reduces the efficiency of top-strand exchange and contributes to the naturally observed bias favouring insertion over excision. Despite these differences, the efficiencies of both reactions are similarly modulated by base pairing between specific dinucleotides in the bRNA, termed handshake guides, and the top strands of the DNA substrates. Overall, this study provides mechanistic insights into the complete IS110 transposition cycle and facilitates the optimal design of programmable bridge-editing applications.


  • Top Cited Papers

    Rapid directed evolution guided by protein language models and epistatic interactions

    by Vincent Q. Tran, Matthew Nemeth, Liam J. Bartie, Sita S. Chandrasekaran, Alison Fanton, Hyungseok C. Moon, Brian L. Hie, Silvana Konermann, Patrick D. Hsu

    Protein engineering is limited by the inefficient search through a high-dimensional sequence space to find combinations of synergistic mutations. Traditional approaches use stepwise mutation stacking, whereas machine learning methods require extensive datasets or multiple experimental rounds and are bottlenecked by costly, length-limited gene synthesis. We present MULTI-evolve (where MULTI stands for model-guided, universal, targeted installation of multimutants), a rapid evolution framework that systematically engineers multimutants. Our approach combines protein language models or existing functional data with epistatic modeling to predict synergistic combinations. Proposed multimutants are built through MULTI-assembly, a mutagenesis method enabling high-efficiency assembly across multikilobase sequences. Applying MULTI-evolve to three proteins achieved up to 10-fold improvements with a single round of machine learning–guided directed evolution. MULTI-evolve provides a streamlined approach for end-to-end, multimutant engineering for a broad range of protein types and functions.


  • Open Access

    A combinatorial domain screening platform reveals epigenetic effector interactions for transcriptional perturbation

    by Hyungseok C. Moon, Michael H. Herschl, Alessandra Sclip, Vincent Q. Tran, April Pawluk, Silvana Konermann, Patrick D. Hsu

    Epigenetic regulation involves the coordinated interplay of diverse proteins. To systematically explore these combinations, we present COMBINE (combinatorial interaction exploration), a high-throughput platform that tests over 50,000 pairs of epigenetic effector domains up to 2,094 amino acids in length for their ability to modulate endogenous human gene transcription. COMBINE reveals diverse synergistic interactions between epigenetic protein domains, including a potent KRAB-L3MBTL3 fusion that increases the effective targeting window, enhances gene silencing in dose-limited conditions, and enables robust dual-directional CRISPR perturbation. Inducible screening shows DNA methylation modifiers are essential for epigenetic memory, with distinct combinations driving long-term repression and activation. This systematic analysis of pairwise domain interactions advances our understanding of epigenetic crosstalks and the development of next-generation epigenome editing tools. More broadly, COMBINE offers a generalizable platform to functionally characterize combinatorial biological processes at scale.


  • Open Access

    BioReason-Pro: Advancing Protein Function Prediction with Multimodal Biological Reasoning

    by Adibvafa Fallahpour, Arman Seyed-Ahmadi, Parsa Idehpour, Omar Ibrahim, Purav Gupta, Jack Naimer, Kevin Zhu, Arnav Shah, Shihao Ma, Abhinav Adduri, et al.

    Protein function annotation is fundamental to understanding biological mechanisms, designing therapeutics, and advancing biomedical research. Current computational methods either rely on shallow sequence similarity or treat function prediction as isolated classification tasks, failing to capture the integrative reasoning across sequence, structure, domains, and interactions that expert biologists perform to infer function. We introduce BioReason-Pro, the first multimodal reasoning large language model (LLM) for protein function prediction that integrates protein embeddings with biological context to generate structured reasoning traces. A key input into BioReason-Pro is the set of GO term predictions made by GO-GPT, our autoregressive transformer that captures hierarchical and cross-aspect dependencies of GO terms. BioReason-Pro is trained via supervised fine-tuning on synthetic reasoning traces generated by GPT-5 for over 130K proteins and further optimized through reinforcement learning. It achieves 73.6% F max on GO term prediction and an LLM judge score of 8/10 on functional summaries, substantially outperforming previous methods. Evaluations with human protein experts show that BioReason-Pro annotations are preferred over ground truth UniProt annotations in 79% of cases. Remarkably, BioReason-Pro de novo predicted experimentally confirmed binding partners with per-residue attention localizing to the exact contact residues resolved in cryo-EM structures of those complexes. Together, GO-GPT and BioReason-Pro establish a framework for protein function prediction that combines precise ontology modeling with interpretable biological reasoning.


  • Top Cited Papers

    Megabase-scale human genome rearrangement with programmable bridge recombinases

    by Nicholas T. Perry, Liam J. Bartie, Dhruva Katrekar, Gabriel A. Gonzalez, Matthew G. Durrant, James J. Pai, Alison Fanton, Juliana Q. Martins, Masahiro Hiraizumi, Chiara Ricci-Tam, et al.

    Bridge recombinases are naturally occurring RNA-guided DNA recombinases that we previously demonstrated can programmably insert, excise, and invert DNA in vitro and in Escherichia coli . In this study, we report the discovery and engineering of the bridge recombinase ortholog ISCro4 for universal rearrangements of the human genome. We defined strategies for the optimal application of bridge systems, leveraging mechanistic insights to improve their targeting specificity. Through rational engineering of the ISCro4 bridge RNA and deep mutational scanning of its recombinase, we achieved up to 20% insertion efficiency into the human genome and genome-wide specificity as high as 82%. We further demonstrated intrachromosomal inversion and excision, mobilizing up to 0.93 megabases of DNA. Lastly, we provided proof of concept for plasmid-based excision of disease-relevant gene regulatory regions or repeat expansions.


  • Top Cited Papers
    Open Access

    Genome modelling and design across all domains of life with Evo 2

    by Garyk Brixi, Matthew G. Durrant, Jerome Ku, Mohsen Naghipourfar, Michael Poli, Gwanggyu Sun, Greg Brockman, Daniel Chang, Alison Fanton, Gabriel A. Gonzalez, et al.

    All of life encodes information with DNA. Although tools for genome sequencing, synthesis and editing have transformed biological research, we still lack sufficient understanding of the immense complexity encoded by genomes to predict the effects of many classes of genomic changes or to intelligently compose new biological systems. Artificial intelligence models that learn information from genomic sequences across diverse organisms have increasingly advanced prediction and design capabilities1,2. Here we introduce Evo 2, a biological foundation model trained on 9 trillion DNA base pairs from a highly curated genomic atlas spanning all domains of life to have a 1 million token context window with single-nucleotide resolution. Evo 2 learns to accurately predict the functional impacts of genetic variation—from noncoding pathogenic mutations to clinically significant BRCA1 variants—without task-specific fine-tuning. Mechanistic interpretability analyses reveal that Evo 2 learns representations associated with biological features, including exon–intron boundaries, transcription factor binding sites, protein structural elements and prophage genomic regions. The generative abilities of Evo 2 produce mitochondrial, prokaryotic and eukaryotic sequences at genome scale with greater naturalness and coherence than previous methods. Evo 2 also generates experimentally validated chromatin accessibility patterns when guided by predictive models3,4 and inference-time search. We have made Evo 2 fully open, including model parameters, training code5, inference code and the OpenGenome2 dataset, to accelerate the exploration and design of biological complexity.


  • Open Access

    Rewriting endogenous human transcripts with dual CRISPR-guided 3′ trans-splicing

    by Sita S. Chandrasekaran, Cyrus Tau, Becky Xu Hua Fu, Matthew Nemeth, Liam Bartie, April Pawluk, Silvana Konermann, Patrick D. Hsu


  • Open Access

    Site-specific DNA insertion into the human genome with engineered recombinases

    by Alison Fanton, Liam J. Bartie, Juliana Q. Martins, Vincent Q. Tran, Laine Goudy, Courtney Kernick, Matthew G. Durrant, Jingyi Wei, Zev Armour-Garb, April Pawluk, et al.

    Insertions of large DNA sequences into the genome are broadly enabling for research and therapeutic applications. Large serine recombinases (LSRs) can mediate direct, site-specific genomic integration of multi-kilobase DNA sequences without a pre-installed landing pad, albeit with low insertion rates and high off-target activity. Here we present an engineering roadmap for jointly optimizing their DNA recombination efficiency and specificity. We combine directed evolution, structural analysis and computational models to rapidly identify additive mutational combinations. We further enhance performance through donor DNA optimization and dCas9 fusions, enabling simultaneous target and donor recruitment. Our top engineered LSR variants, superDn29−dCas9, goldDn29−dCas9 and hifiDn29−dCas9, achieve up to 53% integration efficiency and 97% genome-wide specificity at an endogenous human locus and effectively integrate large DNA cargoes up to 12 kb for stable expression in non-dividing cells, stem cells and primary human T cells. Rational engineering of DNA recombinases enables precise and efficient single-step genome insertion for diverse applications across gene and cell therapies.


  • Open Access

    Megabase-scale human genome rearrangement with programmable bridge recombinases

    by Nicholas T. Perry, Liam J. Bartie, Dhruva Katrekar, Gabriel A. Gonzalez, Matthew G. Durrant, James J. Pai, Alison Fanton, Masahiro Hiraizumi, Chiara Ricci-Tam, Hiroshi Nishimasu, et al.

    Bridge recombinases are a class of naturally occurring RNA-guided DNA recombinases. We previously demonstrated they can programmably insert, excise, and invert DNA in vitro and in bacteria. Here, we report the discovery and engineering of IS622, a simple two-component system capable of universal DNA rearrangements of the human genome. We define strategies for the optimal application of bridge systems, leveraging mechanistic insights to improve their targeting specificity. Through rational engineering of the IS622 bridge RNA and deep mutational scanning of its recombinase, we achieve up to 20% insertion efficiency into the human genome and genome-wide specificity as high as 82%. We further demonstrate intra-chromosomal inversion and excision, mobilizing up to 0.93 megabases of DNA. Finally, we provide proof-of concept for excision of a gene regulatory region or expanded repeats relevant for the treatment of genetic diseases.